Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation

References

• Allen SJ, Wilcock GK, Dawbarn D. 1999. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun 264:648–651
   PubMed Web of Science ®Google Scholar
• Arancibia S, Silhol M, Mouliere F, Meffre J, Hollinger I, Maurice T, Tapia-Arancibia L. 2008. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 31:316–326
   PubMed Web of Science ®Google Scholar
• Assaife-Lopes N, Sousa VC, Pereira DB, Ribeiro JA, Sebastião AM. 2013. Regulation of TrkB receptor translocation to lipid rafts by adenosine A receptors and its functional implications for BDNF-induced regulation of synaptic plasticity. Purinergic Signal 10:251–267
   PubMed Web of Science ®Google Scholar
• Camins A, Verdaguer E, Folch J, Pallas M. 2006. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev 12:135–148
   PubMedGoogle Scholar
• Canas PM, Porciuncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA. 2009. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29:14741–14751
   PubMed Web of Science ®Google Scholar
• Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. 1997. Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res Mol Brain Res 49:71–81
   PubMedGoogle Scholar
• Cunha GM, Canas PM, Melo CS, Hockemeyer J, Muller CE, Oliveira CR, Cunha RA. 2008. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp Neurol 210:776–781
   PubMed Web of Science ®Google Scholar
• Diógenes MJ, Fernandes CC, Sebastião AM, Ribeiro JA. 2004. Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24:2905–2913
   PubMed Web of Science ®Google Scholar
• Diógenes MJ, Assaife-Lopes N, Pinto-Duarte A, Ribeiro JA, Sebastião AM. 2007. Influence of age on BDNF modulation of hippocampal synaptic transmission: Interplay with adenosine A2A receptors. Hippocampus. 17:577–585
   PubMed Web of Science ®Google Scholar
• Diógenes MJ, Costenla AR, Lopes LV, Jerónimo-Santos A, Sousa VC, Fontinha BM, Ribeiro JA, Sebastião AM. 2011. Enhancement of LTP in aged rats is dependent on endogenous BDNF. Neuropsychopharmacology 36:1823–1836
   PubMed Web of Science ®Google Scholar
• Diógenes MJ, Neves-Tome R, Fucile S, Martinello K, Scianni M, Theofilas P, Lopatár J, et al. 2014. Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase. Cereb Cortex 24:67–80
   PubMed Web of Science ®Google Scholar
• Dall'Igna OP, Porciuncula LO, Souza DO, Cunha RA, Lara DR. 2003. Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol 138:1207–1209
   PubMed Web of Science ®Google Scholar
• Eide FF, Vining ER, Eide BL, Zang K, Wang XY, Reichardt LF. 1996. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci 16:3123–3129
   PubMed Web of Science ®Google Scholar
• Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Marti E. 1999. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58:729–739
   PubMed Web of Science ®Google Scholar
• Fifre A, Sponne I, Koziel V, Kriem B, Yen Potin FT, Bihain BE, Olivier JL, et al. 2006. Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J Biol Chem 281:229–240
   PubMed Web of Science ®Google Scholar
• Fontinha BM, Diógenes MJ, Ribeiro JA, Sebastião AM. 2008. Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology 54:924–933
   PubMed Web of Science ®Google Scholar
• Glenner GG and Wong CW. 1984. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890
   PubMed Web of Science ®Google Scholar
• Granic I, Nyakas C, Luiten PG, Eisel UL, Halmy LG, Gross G, Schoemaker H, et al. 2010. Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats. Neuropharmacology 59:334–342
   PubMed Web of Science ®Google Scholar
• Han BH, D’Costa A, Back SA, Parsadanian M, Patel S, Shah AR, Gidday JM, et al. 2000. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 7:38–53
   PubMed Web of Science ®Google Scholar
• Hayashi H, Campenot RB, Vance DE, Vance JE. 2009. Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J Biol Chem 284:29605–29613
   PubMed Web of Science ®Google Scholar
• Higuchi M, Tomioka M, Takano J, Shirotani K, Iwata N, Masumoto H, Maki M, et al. 2005. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J Biol Chem 280:15229–15237
   PubMed Web of Science ®Google Scholar
• Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. 2000. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription–polymerase chain reaction: Decreased levels in Alzheimer’s disease. Brain Res Mol Brain Res 76:347–354
   PubMedGoogle Scholar
• Huang EJ, Reichardt LF. 2001. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24:677–736
   PubMed Web of Science ®Google Scholar
• Jerónimo-Santos A, Batalha VL, Muller CE, Baqi Y, Sebastião AM, Lopes LV, Diógenes MJ. 2014. Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP. Neuropharmacology 83:99–106
   PubMed Web of Science ®Google Scholar
• Jerónimo-Santos A, Vaz SH, Parreira S, Rapaz-Lerias S, Caetano AP, Buee-Scherrer V, Castren E, et al. 2015. Dysregulation of TrkB receptors and BDNF Function by amyloid-beta peptide is mediated by calpain. Cereb Cortex 25:3107–3121
   PubMedGoogle Scholar
• Jeon SJ, Rhee SY, Ryu JH, Cheong JH, Kwon K, Yang SI, Park SH, et al. 2011. Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons. Neurochem Res 36:2259–2269
   PubMed Web of Science ®Google Scholar
• Kemppainen S, Rantamaki T, Jerónimo-Santos A, Lavasseur G, Autio H, Karpova N, Karkkainen E, et al. 2012. Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging 33:1122–1139
   PubMed Web of Science ®Google Scholar
• Kim DH, Zhao X. 2005. BDNF protects neurons following injury by modulation of caspase activity. Neurocrit Care 3:71–76
   PubMed Web of Science ®Google Scholar
• Lakk M, Denes V, Gabriel R. 2015. Pituitary adenylate cyclase-activating polypeptide receptors signal via phospholipase C pathway to block apoptosis in newborn rat retina. Neurochem Res 40:1402–1409
   PubMed Web of Science ®Google Scholar
• Lee FS, Chao MV. 2001. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A 98:3555–3560
   PubMed Web of Science ®Google Scholar
• Lesne S, Gabriel C, Nelson DA, White E, Mackenzie ET, Vivien D, Buisson A. 2005. Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta}xicity. J Biol Chem 280:24941–24947
   PubMed Web of Science ®Google Scholar
• Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. 2013. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14:401–416
   PubMed Web of Science ®Google Scholar
• Melo CV, Okumoto S, Gomes JR, Baptista MS, Bahr BA, Frommer WB, Duarte CB. 2013. Spatiotemporal resolution of BDNF neuroprotection against glutamate excitotoxicity in cultured hippocampal neurons. Neuroscience 237:66–86
   PubMed Web of Science ®Google Scholar
• Momeni HR. 2011. Role of calpain in apoptosis. Cell J 13:65–72
   PubMed Web of Science ®Google Scholar
• Peng S, Wuu J, Mufson EJ, Fahnestock M. 2005. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93:1412–1421
   PubMed Web of Science ®Google Scholar
• Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. 1995. Structure-activity analyses of beta-amyloid peptides: Contributions of the beta 25–35 region to aggregation and neurotoxicity. J Neurochem 64:253–265
   PubMed Web of Science ®Google Scholar
• Pousinha PA, Diógenes MJ, Ribeiro JA, Sebastião AM. 2006. Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors. Neurosci Lett 404:143–147
   PubMed Web of Science ®Google Scholar
• Rajagopal R, Chen ZY, Lee FS, Chao MV. 2004. Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24:6650–6658
   PubMed Web of Science ®Google Scholar
• Raynaud F and Marcilhac A. 2006. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer’s disease. FEBS J 273:3437–3443
   PubMed Web of Science ®Google Scholar
• Rebola N, Rodrigues RJ, Oliveira CR, Cunha RA. 2005. Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons. Neurochem Int 47:317–325
   PubMed Web of Science ®Google Scholar
• Ribeiro JA, Sebastião AM, de Mendonca A. 2002. Adenosine receptors in the nervous system: Pathophysiological implications. Prog Neurobiol 68:377–392
   PubMed Web of Science ®Google Scholar
• Ribeiro FF, Neves-Tome R, Assaife-Lopes N, Santos TE, Silva RF, Brites D, Ribeiro JA, et al. 2015. Axonal elongation and dendritic branching is enhanced by adenosine A receptors activation in cerebral cortical neurons. Brain Struct Funct. [Epub ahead of print]. doi: 10.1007/s00429-015-1072-1
   PubMedGoogle Scholar
• Rodrigues TM, Jerónimo-Santos A, Outeiro TF, Sebastião AM, and Diógenes MJ. 2014. Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson's Disease. Drugs Aging 31:239–261
   PubMed Web of Science ®Google Scholar
• Rodrigues TM, Jerónimo-Santos A, Sebastião AM, Diógenes MJ. 2014. Adenosine A(2A) Receptors as novel upstream regulators of BDNF-mediated attenuation of hippocampal Long-Term Depression (LTD). Neuropharmacology 79:389–398
   PubMed Web of Science ®Google Scholar
• Sebastião AM, Assaife-Lopes N, Diógenes MJ, Vaz SH, Ribeiro JA. 2011. Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts. Biochim Biophys Acta 1808:1340–1349
   PubMed Web of Science ®Google Scholar
• Segal RA, Greenberg ME. 1996. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19:463–489
   PubMed Web of Science ®Google Scholar
• Smith MA, Schnellmann RG. 2012. Calpains, mitochondria, and apoptosis. Cardiovasc Res 96:32–37
   PubMed Web of Science ®Google Scholar
• Sommerfeld MT, Schweigreiter R, Barde YA, Hoppe E. 2000. Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J Biol Chem 275:8982–8990
   PubMed Web of Science ®Google Scholar
• Sun Z, Ma X, Yang H, Zhao J, Zhang J. 2012. Brain-derived neurotrophic factor prevents beta- amyloid-induced apoptosis of pheochromocytoma cells by regulating Bax/Bcl-2 expression. Neural Regen Res 7:347–351
   Web of Science ®Google Scholar
• Tebano MT, Martire A, Potenza RL, Gro C, Pepponi R, Armida M, Domenici MR, et al. 2008. Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J Neurochem 104:279–286
   PubMed Web of Science ®Google Scholar
• Valadas JS, Batalha VL, Ferreira DG, Gomes R, Coelho JE, Sebastião AM, Diógenes MJ, Lopes LV. 2012. Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons. J Neurochem 123:1030–1040
   PubMed Web of Science ®Google Scholar
• Vasefi MS, Kruk JS, Heikkila JJ, Beazely MA. 2013. 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFbeta receptor dependent. J Neurochem 125:26–36
   PubMed Web of Science ®Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
   PubMed Web of Science ®Google Scholar
• Wang KK. 2000. Calpain and caspase: Can you tell the difference? Trends Neurosci 23:20–26
   PubMed Web of Science ®Google Scholar
• Wei Z, Song MS, MacTavish D, Jhamandas JH, Kar S. 2008. Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons. Neuropharmacology 54:721–733
   PubMed Web of Science ®Google Scholar
• Zadran S, Jourdi H, Rostamiani K, Qin Q, Bi X, Baudry M. 2010. Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J Neurosci 30:1086–1095
   PubMed Web of Science ®Google Scholar
• Zhou H, Li XM, Meinkoth J, Pittman RN. 2000. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151:483–494
   PubMed Web of Science ®Google Scholar